Astellas Patient Assistance Program
The Astellas Patient Assistance Programa (PAP) provides Myrbetriq® (mirabegron) extended-release tablets at no cost to patients who meet the program eligibility requirements.
Myrbetriq Support Solutionsb can assess whether the patient meets the eligibility requirements. For more information, contact us at 1-800-477-6472. We are available Monday–Friday, 9:00 am–8:00 pm ET.
The patient may be eligible if they meet the following criteria:
- Be uninsured or have insurance that excludes coverage for Myrbetriq
- Have a verifiable shipping address in the United States
- Have been prescribed Myrbetriq for an FDA-approved indication
- Meet the program financial eligibility requirements
After receiving the completed PAP Application Form for Myrbetriq, we will evaluate and determine if the patient is eligible for this program. If the patient is eligible, we will notify you and the patient, and ship a supply of Myrbetriq directly to the patient's home.
a The program is void where prohibited by law.
b Myrbetriq Support Solutions is a component of Astellas Pharma Support SolutionsSM.
Myrbetriq® is a registered trademark of Astellas Pharma Inc.